Columnist Sam Kirton is doing a service for him and his family's future generations by sharing his research on the family ...

The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...

Living with IPF is never dull, says columnist Sam Kirton, who shares some updates on topics he's discussed in recent columns.

CAL101, an investigational therapy with the potential to treat pulmonary fibrosis, showed a favorable safety and pharmacological profile in a Phase 1 clinical trial, according to results announced by ...

Sam Kirton started his column in November 2021 and writes from his home at Lake Anna, Virginia, where he lives with his wife Susan. His diagnosis at age 59 with idiopathic pulmonary fibrosis in ...

Frequent appointments and testing are part of life with idiopathic pulmonary fibrosis (IPF). I’ve been living with IPF for eight years now, but the number of those appointments and tests can still ...

Insilico Medicine’s ISM001-055 was generally safe and improved lung function in people with idiopathic pulmonary fibrosis (IPF), according to top-line data from a Phase 2a trial. The trial ...

Researchers have identified a type of pro-fibrotic immune cell associated with pulmonary fibrosis (PF) in people who develop persistent breathing problems after recovering from COVID-19. The cells’ ...

What medications do you take regularly, and what are they for? Do you know the possible side effects? When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in January 2017, I didn’t take many ...

When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in January 2017, there didn’t seem to be as much chaos in the world as there is today. Perhaps the drama seemed more distant, or maybe I ...